SYDNEY SPURLING: Open Payments
NPI 1407582059 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 32 payments from 13 companies in 2025. Trend: 2023 $200 · 2024 $692 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $254 |
| Boston Scientific Corporation | 4 | $81 |
| PFIZER INC. | 3 | $56 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| ABIOMED | 1 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $26 |
| CVRx, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: LEQVIO, WATCHMAN FLX, ELIQUIS, INSPIRE, REPATHA, LifeVest, Barostim Neo System, ENTRESTO.
Industry payments across GA — which companies pay providers there.
